NCT07012850

Brief Summary

Dental, oral, and maxillofacial trauma represents a significant public health concern, with most cases resulting from accidents and occurring frequently in young adults. Diagnosis relies on clinical examination and imaging modalities like computed tomography (CT) and cone-beam computed tomography (CBCT), which are standard for hard tissue assessment but expose patients to ionizing radiation. To reduce radiation exposure while simultaneously allowing for the visualization of soft tissues, newer imaging methods, including magnetic resonance imaging (MRI), as well as Black Bone and CT-like MRI protocols (ZTE, UTE), are being explored. These MRI techniques offer high-resolution, non-ionizing alternatives, showing promise for diagnosing soft tissue injuries and fractures without radiation risks, especially beneficial for younger patients. This study aims to assess MRI's diagnostic capabilities for maxillofacial trauma, focusing on early diagnosis, artifact reduction, and comparison to conventional X-ray-based imaging, within a minimal-risk study framework. This study aims to evaluate the diagnostic efficacy of MRI compared to X-ray-based imaging modalities (CT/CBCT) for detecting dental, oral, and maxillofacial fractures, with a specific focus on Black Bone and CT-like MRI techniques. Additionally, it investigates MRI's potential to reduce artifacts around osteosynthesis plates, enhancing postoperative imaging quality in the presence of metal hardware.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 5, 2025

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

May 9, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 10, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

June 10, 2025

Status Verified

May 1, 2025

Enrollment Period

8 months

First QC Date

May 9, 2025

Last Update Submit

June 4, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • qualitative imaging parameters

    Primary Outcome Measures: 1\. Qualitative Assessment of Imaging Quality Description: Image quality will be evaluated using a standardized 5-point Likert scale for the following parameters: overall image quality, artifact severity, fracture visibility, and bone-to-soft-tissue contrast. Each parameter will be scored independently. Unit of Measure: Score on a 5-point Likert scale (1 = poor, 5 = excellent)

    From enrollment to the end of treatment at week 5

  • Quantitative Assessment of Fracture Dimensions

    Fracture length, width, and depth will be measured in millimeters across axial, sagittal, and coronal planes using standardized digital radiologic tools. Measurements will be taken by two blinded radiologists and averaged. Unit of Measure: Millimeters (mm).

    From enrollment to the end of treatment at week 5

Interventions

To reduce radiation exposure while simultaneously allowing for the visualization of soft tissues, newer imaging methods, including magnetic resonance imaging (MRI), as well as Black Bone and CT-like MRI protocols (ZTE, UTE), are being explored. These MRI techniques offer high-resolution, non-ionizing alternatives, showing promise for diagnosing soft tissue injuries and fractures without radiation risks.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study Population from the University Hospital Zurich, Switzerland

You may qualify if:

  • Patients presenting with acute dental, oral and maxillofacial trauma
  • Age: 18 years and older
  • Able to give informed consent (documented by signature)
  • No prior radiation-based imaging for the current trauma episode

You may not qualify if:

  • Pregnant or lactating individuals
  • Known contraindications to MRI (e.g., pacemakers, certain implants)
  • Clinically significant concomitant diseases affecting imaging quality (e.g., severe neurocognitive disorders)
  • Inability to comply with MRI procedures or study protocol (e.g., due to language barriers, psychological disorders, or dementia)
  • Participation in other clinical trials that may interfere with the imaging study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cranio-Maxillofacial and Oral Surgery, University Hospital Zurich

Zurich, Canton of Zurich, 8091, Switzerland

Location

MeSH Terms

Conditions

Maxillofacial Injuries

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Facial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesWounds and Injuries

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. med. Dr. med. dent.

Study Record Dates

First Submitted

May 9, 2025

First Posted

June 10, 2025

Study Start

May 5, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

June 10, 2025

Record last verified: 2025-05

Locations